Safety and tolerability of tirbanibulin ointment 1% treatment on 100 cm2 of the face or scalp in patients with actinic keratosis: A phase 3 studyCapsule Summary

• Main Authors: Neal Bhatia, MD (Author), Edward Lain, MD (Author), Abel Jarell, MD (Author), Janet DuBois, MD (Author), Maria Luisa Tamarit, MD (Author), Meritxell Falques, MSc (Author), Vera Kiyasova, MD, PhD (Author), Laura Padullés, PhD (Author), Raquel Otero, PhD (Author), Andrew Blauvelt, MD, MBA (Author)
• Format: Book
• Published: Elsevier, 2024-12-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Background: Tirbanibulin is approved for actinic keratosis (AK) field treatment up to 25 cm2. However, AK often affects larger areas; thus, AK treatments for larger fields are needed. Objective: Evaluate the safety and tolerability of tirbanibulin when applied to a field of approximately 100 cm2. Me...